Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument
Journal of Medical Internet Research · 30.06.2023 · 25 · e47479
DOI: 10.2196/47479 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 30.06.2023. Verfasst von Harriet Louise Walker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Royal Free London NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Artificial Intelligence, Health Personnel. Die Arbeit wurde bisher 375-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
ChatGPT-4 is the latest release of a novel artificial intelligence (AI) chatbot able to answer freely formulated and complex questions. In the near future, ChatGPT could become the new standard for health care professionals and patients to access medical information. However, little is known about the quality of medical information provided by the AI.
Objective
We aimed to assess the reliability of medical information provided by ChatGPT.
Methods
Medical information provided by ChatGPT-4 on the 5 hepato-pancreatico-biliary (HPB) conditions with the highest global disease burden was measured with the Ensuring Quality Information for Patients (EQIP) tool. The EQIP tool is used to measure the quality of internet-available information and consists of 36 items that are divided into 3 subsections. In addition, 5 guideline recommendations per analyzed condition were rephrased as questions and input to ChatGPT, and agreement between the guidelines and the AI answer was measured by 2 authors independently. All queries were repeated 3 times to measure the internal consistency of ChatGPT.
Results
Five conditions were identified (gallstone disease, pancreatitis, liver cirrhosis, pancreatic cancer, and hepatocellular carcinoma). The median EQIP score across all conditions was 16 (IQR 14.5-18) for the total of 36 items. Divided by subsection, median scores for content, identification, and structure data were 10 (IQR 9.5-12.5), 1 (IQR 1-1), and 4 (IQR 4-5), respectively. Agreement between guideline recommendations and answers provided by ChatGPT was 60% (15/25). Interrater agreement as measured by the Fleiss κ was 0.78 (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Royal Free London NHS Foundation Trust, London, United Kingdom.
- Clarunis - University Center for Gastrointestinal and Liver Diseases, Basel, Switzerland.
- Departement Chirurgie, Kantonsspital Aarau, Aarau, Switzerland.
- Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
ORCID-Profile: Harriet Louise Walker, Shahi Ghani, Christoph Kuemmerli, Christian Andreas Nebiker, Beat Peter Müller, Dimitri Aristotle Raptis, Sebastian Manuel Staubli
Zitieren
APA
Walker, H. L., Ghani, S., Kuemmerli, C., Nebiker, C. A., Müller, B. P., Raptis, D. A., & Staubli, S. M. (2023). Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument. Journal of Medical Internet Research, 25, e47479. https://doi.org/10.2196/47479
Vancouver
Walker HL, Ghani S, Kuemmerli C, Nebiker CA, Müller BP, Raptis DA, et al. Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument. Journal of Medical Internet Research. 2023;25:e47479. doi:10.2196/47479
BibTeX
@article{Walker2023,
author = {Walker, Harriet Louise and Ghani, Shahi and Kuemmerli, Christoph and Nebiker, Christian Andreas and Müller, Beat Peter and Raptis, Dimitri Aristotle and Staubli, Sebastian Manuel},
title = {Reliability of Medical Information Provided by ChatGPT: Assessment Against Clinical Guidelines and Patient Information Quality Instrument},
journal = {Journal of Medical Internet Research},
year = {2023},
volume = {25},
pages = {e47479},
doi = {10.2196/47479}
}
EUVIMED